Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 21, 2013

Primary Completion Date

May 5, 2013

Study Completion Date

May 5, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

Dapsone Formulation A

Dapsone Formulation A applied once daily to the face, upper chest, upper back, and shoulders for 28 days.

DRUG

Dapsone Formulation B

Dapsone Formulation B applied once daily to the face, upper chest, upper back, and shoulders for 28 days.

DRUG

Dapsone Formulation C

Dapsone Formulation C applied once daily to the face, upper chest, upper back, and shoulders for 28 days.

DRUG

Dapsone 5% Gel

Dapsone 5% gel (ACZONE®) applied twice daily to the face, upper chest, upper back, and shoulders for 28 days.

Trial Locations (1)

Unknown

College Station

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01773122 - Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris | Biotech Hunter | Biotech Hunter